Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Q1 2024 Earnings Call Transcript
Ironwood Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $0.08927 EPS, expectations were $0.18. Ironwood Pharmaceuticals, Inc.
Ironwood Pharmaceuticals Inc (IRWD)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Sarissa Capital Management Alex Denner | 16,390,000 | $142,756,900 | 24.97% | |
| 2. | 52,740,000 | $53,701,147 | +241% | 1.73% | |
| 3. | Armistice Capital Steven Boyd | 5,400,000 | $47,034,000 | -6% | 0.62% |
| 4. | Braidwell LP Alex Karnal | 3,489,843 | $30,396,533 | 0.97% | |
| 5. | GLG Partners Noam Gottesman | 2,985,313 | $26,002,077 | +110% | 0.06% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $8.70 | 6,920 | 121,028 | 2024-03-06 | Filing | ||
| $9.38 | 10,684 | 301,733 | 2024-03-04 | Filing | ||
| $8.32 | 36,072 | Officer | 188,730 | 2023-09-15 | Filing | |
| $10.54 | 75,000 | Large Shareholder, Director | 16,390,000 | 2021-03-10 | Filing | |
| $10.30 | 150,000 | Large Shareholder, Director | 16,315,000 | 2021-03-08 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $6.29 | 22,766 | 139,528 | 2024-06-10 | Filing | ||
| $6.61 | 35,574 | 48,633 | 2024-06-07 | Filing | ||
| $6.36 | 44,426 | 84,207 | 2024-06-06 | Filing | ||
| $6.45 | 67,618 | 1,150,330 | 2024-05-20 | Filing | ||
| $6.45 | 22,725 | 288,031 | 2024-05-20 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 25,980,308 | $297,214,723 | 0% | |
| 2. | 16,033,545 | $183,423,755 | 0% | |
| 3. | 11,532,088 | $131,927,087 | 0% | |
| 4. | 5,612,113 | $64,202,573 | 0.06% | |
| 5. | 47,700,000 | $50,204,252 | 0.15% |
News See All
5 Best Low Price Pharma Stocks To Invest In
In this piece, we will take a look at the five best low price pharma stocks to invest in.
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Q4 2023 Earnings Call Transcript
Ironwood Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-0.01 EPS, expectations were $0.2.
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Q3 2023 Earnings Call Transcript
Operator: Thank you for standing by. My name is Aaron, and I will be your conference operator for today.
Top 5 Extreme Value Stocks To Buy
Donnelley Financial Solutions, Inc. (NYSE:DFIN) was the financial segment of R.R. Donnelley & Sons but was established as an independent corporation in 2016.
Hedge Fund and Insider Trading News: Cathie Wood, Steve Cohen, Ress Capital, Brevan Howard Asset Management, ExodusPoint Capital Management, CNX Resources Corp (CNX), Iovance Biotherapeutics, Inc. (IOVA), and More
Investors will flock to funds focusing on buzzy themes when the Federal Reserve cuts interest rates, according to Cathie Wood, who is doubling down on innovative investment strategies with a new acquisition...
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Q2 2023 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. My name is Sharell and I will be your conference operator today.
10 Best Small Cap Pharma Stocks to Buy
In this piece, we will take a look at the ten best small cap pharma stocks to buy.
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Q1 2023 Earnings Call Transcript
Operator: Good day, and welcome to the Ironwood Pharmaceuticals Q1 2023 Investor Update Conference Call. Today's call is being recorded [Operator Instructions].
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Q4 2022 Earnings Call Transcript
Operator: Good day, and welcome to the Ironwood Pharmaceuticals Q4 and Full Year 2022 Investor Update Conference Call. Today's call is being recorded. . Thank you.
Billionaire Hedge Funds
